Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...

Benign prostatic hyperplasia (BPH) is one of the most common urologic conditions affecting men as they age, with nearly 50% of men over 50 experiencing symptoms. Despite its prevalence, treatment ...

When robotics and cloud-connected digital twins work in sync, they create a living, responsive system that continually ...

With more than 2,000 citations and year-over-year growth nearing 80%, TriNetX outpaces competitors and fuels high-impact science published in top medical journals. CAMBRIDGE, Mass., Oct. 15, 2025 ...

Until recently, the most effective protection against respiratory syncytial virus (RSV) was only available for high-risk infants, and many parents and providers may remember the vulnerability that ...

It is part of OpenAI’s efforts to compare the performance of its AI models against an established human baseline for various ...

Amtagvi shows a 48.8% ORR in advanced melanoma, with higher efficacy in less heavily treated patients. FDA granted accelerated approval for Amtagvi in 2024 for unresectable or metastatic melanoma ...

Inovalon, a leading provider of data and solutions empowering data-driven healthcare, announced its real-world data and analytics supported Forbes’ inaugural Top Hospitals List & Ratings, released ...